Kwas stearydonowy C18:4 [N-3] - zrodla roslinne i potencjalne znaczenie w zywieniu czlowieka

• Autorzy: Dzik J

Warianty tytułu

EN

Stearidonic acid C18:4 [N-3] - its plant sources and the potential importance in human nutrition

• Języki publikacji: PL

Słowa kluczowe

PL

surowce roslinne; kwas stearydonowy; kwasy tluszczowe wielonienasycone; dieta; metabolizm czlowieka; zywienie czlowieka

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2005
• Tom: 32
• Numer: 1
• Opis fizyczny: s.56-64,rys.,tab.,bibliogr.

Twórcy

autor

Dzik J

• Politechnika Gdanska, Gdansk

Bibliografia

• 1. Abeywardena M., Head R.: Longehain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovascular Res., 2001, 52, 361.
• 2. Agostoni C., Scaglioni S., Bonvissuto M., et al.: Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia. Prost. Leuk. EFA 2001, 64, 2, 111.
• 3. Antueno R., Elliot M., Horrobin E: Liver D5 and D6 desaturase activity differs among laboratory rat strains. Lipids 1994, 29, 5, 327.
• 4. Antueno R., Knickle L., Smith H., et al.: Activity of human Δ5 and Δ6 desaturases on multiple n-3 and n-6 polyunsaturated fatty acids. FEBS Letters. 2001, 509, 77.
• 5. Babcock T., Helton W, Espat N.: Eicosapentaenoic acid (EPA): an anti-inflammatory w-3 fat with potential clinical applications. Nutrition 2000, 16, 1116.
• 6. Bao D., Mori T., Burke V, et al: Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 1998, 32, 4, 710.
• 7. Brox J., Olaussen K, Osterud B., et al.: A long-term seal- and cod-liver-oil supplementation in hypercho- lesterolemic subjects. Lipids 2001, 36, 7
• 8. Cabre E., Gassull M.: Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance. Nutrition 1996, 12, 542-8.
• 9. Callaway J., Tennil T., Pate D.: Occurrence of ,,omega-3" stearidonic acid (cis-6,9,12,15-octadecatetraenoic acid) in hemp (Cannabis sativa L.) seed. J. International Hemp Assoc. 1996,3,61-63.
• 10. Chi M., Ray R., Williams D., et al.: Effects of dietary fat on blood pressure and plasma lipids in spontaneously hypertensive rats. Nutr. Res., 1999, 19, 6, 917-25.
• 11. Christensen J., Schmidt E.: n-3 Fatty acids and the risk of sudden cardiac death. Lipids 2001, 36, 115.
• 12. Cunnane S., et al.: Utilization of [U-13C]-poly- unsaturated fatty acids in the synthesis of long chain fatty acids and cholesterol accumulating in the neonatal rat brain. J. Neurochem 1994, 62, 2429.
• 13. Cunnane S.: New developments in a-linolenate metabolism with emphasis on the importance of ß-oxidation and carbon recycling. 4 th Congress: Fatty Acids and Lipids - New Findings. Tsukuba, Japan, World Review of Nutrition and Dietetics 2000, 88, 179.
• 14. Dyerberg J., Bang H., Aagaard O.: a-Linolenic acid and eicosapentaenoic acid. Lancet 1980, 26, 199.
• 15. Eck M. i wsp.: Fatty acid desaturation in experimental diabetes mellitus. Diabetes 1979, 28, 479.
• 16. Eder K., Kirchgessner M.: Dietary zinc deficiency and fatty acid metabolism in rats. Nutr Res., 1996, 16, 1179.
• 17. El-Shazly A., et al.: Pyrrolizidine and tetrahydroisoquinoline alkaloids from Echium humile. Phytochemistry 1996, 42, 225-230.
• 18. Engler M., Engler M.: The effects of dietary evening primrose, black currant, borage and fungal oils on plasma, hepatic and vascular tissue fatty acid composition in the spontaneously hypertensive rat. Nutr. Res., 1998, 18, 1533.
• 19. FAO/WHO. Fats and oils in human nutrition. Report of joint expert consultation, FAO Food and Nutrition Paper. 1993, 57, Rome.
• 20. Gillis R., Daley B., Enderson B., et al.: Eicosapentaenoic acid and g-linolenic acid induce apoptosis in HL-60 cells. J. Surg. Res., 2002, 107, 145-53.
• 21. Grimsgaard S., Bonaa K., Hansen J., et al.: Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerols-lowering effects but divergent effects on serum fatty acids. Am. J. Clin. Nutr., 1997, 66, 3, 649.
• 22. Grys S.: Rola kwasu gamma-linolenowego w ustroju człowieka. Mat. z sympozjum naukowego „Olej z nasion wiesiołka w profilaktyce i terapii" 1995, Łódź.
• 23. Grys S.: Patologiczne efekty rozkojarzenia metabolizmu kwasów tłuszczowych rodzin n-6 i n-3 w organizmie człowieka. Mat. z sympozjum naukowego "Olej z nasion wiesiołka i inne oleje, zawierające kwasy n-6 lub n-3, w profilaktyce i terapii" 1998, Sulejów.
• 24. Guil-Guerrero J., et al.: Gamma-linolenic acid from fourteen boraginaceae species. Industrial Crops and Products 2003, 18, 85-89.
• 25. Guil-Guerrero J., Gomez-Mercado F., Garcia-Maroto F, et al.: Occurrence and characterization of oils rich in g-linolenic acid, Part I: Echium seeds from Macaronesia. Phytochemistry 2000, 53, 451.
• 26. Hamazaki K., Itomura M., Huan M., et al.: n-3 Long-chain FA decrease serum levels of TG and remnant-like particle-cholesterol in humans. Lipids 2003, 38, 353.
• 27. Harmon S., et al.: Effect of the Δ6-desaturase inhibitor S.C.-26196 on PUFA metabolism in human cells. Lipids 2003, 38, 469.
• 28. James M., Ursin V, Cleland L.: Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am. J. Clin. Nutr., 2003, 77, 1140.
• 29. Jeffrey B., Weisinger H., Neuringer M., et al.: The role of docosahexaenoic acid in retinal function. Lipids 2001, 36, 859.
• 30. Jonge H., Dekkers D., Bastiaanse E., et al.: Eicosapentaenoic acid incorporation in membrane phospholipids modulates receptor-mediated phospholipase C and membrane fluidity in rat ventricular myocytes in culture. J. Mol. Cell. Cardiol., 1996, 28, 1097-1108.
• 31. Jonnalagadda S., Egan S., Heimbach J., et al.: Fatty acid consumption pattern of americans: 1987-1988 USDA Nationwide Food Consumption Survey. Nutr. Res., 1995, 15, 12, 1767.
• 32. Leaf A.: The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain. Lipids 2001, 36, 107.
• 33. Lombardo Y., Chicco A., D'Alessandro M., et al.: Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim. Biophys. Acta., 1996, 1299, 175
• 34. Marra C., Rimoldi O., de Alaniz M.: Correlation between fatty acyl composition in neutral and polar lipids and enzyme activities from various tissues of calcium-deficient rats. Lipids 2002, 37, 7, 701.
• 35. McLennan E: Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 2001, 36, 111.
• 36. Menard C., et al.: Recycling of carbon into lipids synthesized de novo is a quantitatively important pathway of [U-13C]-a-linolena- te utilization in the developing rat brain. J. Neurochem 1998, 71, 2151.
• 37. Nervi A., et al.: Effect of ethanol administration on fatty acid desaturation. Lipids 1980, 15, 263.
• 38. Nobukata H., et al.: Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Metabolism 2000, 49, 912.
• 39. Park Y., Harris W.: EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids 2002, 37, 10, 941.
• 40. Peck L.: Essential fatty acid deficiency in renal failure: Can supplements really help? J. Am. Diet. Assoc., 1997, 97, 10, 150-53.
• 41. Prakash A., Pereira T., Reilly P, Seawright A.: Pyrrolidine alkaloids in human diet. Mutation Research 1999, 443, 53.
• 42. Retterstol K., et al.: Metabolism of some radiolabeled essential fatty acids in isolated rat hepatocytes is affected by dietary ethanol. Alcohol 2000, 21, 19
• 43. Richardson A., Easton T., Puri B.: Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. European Neuropsychophar- macology 2000, 10, 189.
• 44. Sato S., Xing A., Ye X., et al.: Production of у-linole- nic acid and stearidonic acid in seeds of marker-free transgenic soybean. Crop Sei., 2004, 44, 646
• 45. Sayanova O., Napier J., Shewry P: D6-Unsaturated fatty acids in species and tissues of the primulaceae. Phytochemistry 1999, 52, 419.
• 46. Scho- thorst R., Jekel A.:Results of analysis of the 1994 dutch duplicate 24-hour diet samples: fatty acids. Food Chem., 2000, 70, 515.
• 47. Sidhu K.: Health benefits and potential risks related to consumptionof fish or fish oil. Regulatory Toxicology and Pharmacology 2003, 38, 336.
• 48. Simopoulos A., Leaf A., Salem N.: Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prost. Leuk. EFA 2000, 63, 3, 119.
• 49. Sinclair A., Attar-Bashi N., Li D.: What is the role of a-linolenic acid for mammals? Lipids 2002, 37, 1113.
• 50. Stołyhwo-Szpajer M., Piękosz K., Bellwon J.: Wielonienasycone kwasy tłuszczowe i ich wpływ na czynniki ryzyka miażdżycy ze szczególnym uwzględnieniem ciśnienia tętniczego. Arterial Hypertension 2001, 5, 3, 211-19.
• 51. Stołyhwo A., i wsp.: Naturalne źródła metabolitów kwasu alfa-linolenowego C18:3 n-3 ze szczególnym uwzględnieniem kwasu stearidonowego C18:4 n-3 i produktów jego przemian w organizmie ludzkim. Raport z realizacji PB KBN 4P05D00618, Gdańsk 2002.
• 52. Surette M., Edens M., Chilton F, et al.: Dietary Echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacyl- glycerols in hypertriglyceridemic humans. J. Nutr., 2004, 134, 6, 1406
• 53. Swann E, Venton D., Le Breton G.: Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2 / prostaglandin H2 receptor in human platelets. FEB 1989, 243, 2, 244.
• 54. Thies F, Nebe-von-Caron G., Powell J., et al.: Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am. J. Clin. Nutr., 2001, 73, 3, 539.
• 55. Velasco L., Goffman F.: Chemotaxonomic significance of fatty acids and tocopherols in Boraginaceae. Phytochemistry 1999, 52, 423.
• 56. Watanab A., Saito S., Tsuchida T., et al.: Low plasma levels of docosahexaenoic acid in patients with liver cirrhosis and its correction with a polyunsaturated fatty acid-enriched soft oil capsule. Nutrition 1999, 15, 4, 284.
• 57. Williard D., et al.: Identification of a fatty acid Δ6- desaturase deficiency in human skin fibroblasts. J. Lipid Res., 2001, 42, 501.
• 58. Williard D., et al.: Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J. Lipid Res., 2001, 42, 1368.
• 59. Yamada M., Omata K., Abe F., et al.: Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia. Immunopharmacology 1999, 44, 193.
• 60. Yamazaki K., et al.: Comparison of the conversion rates of a-linolenic acid (18:3 (n-3)) and stearidonic acid (18:4 (n-3)) to longer polyunsaturated fatty acids in rats, Biochim. Biophys. Acta 1992, 1123, 18-25.
• 61. Yosefy C, Viskoper J., Laszt A., et al.: The effect of fish oil on hypertension, plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus. Prost. Leuk. EFA 1999, 61, 2, 83.
• 62. Ziemlański Ś., Budzyńska-Topolowska J.: Współczesne poglądy na rolę fizjologiczną wielonienasyconych kwasów tłuszczowych z rodziny n-3. Żyw. Człow. Metab. 1992, 19, 2.